Digital health and service companies at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
52 digital health and service companies are at ObesityWeek 2026 — 83 presentations on the program and 9 with a booth in the exhibit hall. Most represented: Ro (6 on the program), Virta Health (3 on the program), Enara Health (2 on the program). 28 of them have their own page in this guide. As of Nov 12, 2026.
Topic
Top represented
Showing 1–11 of 52 organizations
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Ro New York, NY | |
Direct-to-patient telehealth company offering online treatment, including weight-management care with GLP-1 medications. | Poster Sun Nov 15 2:30pm–3:30pm 3-Month Weight Outcomes with Oral Semaglutide via Telehealth in Adults with Overweight or Obesity Clinical obesity care and professional practicePopulation health and epidemiology Poster Sun Nov 15 2:30pm–3:30pm Clinical Eligibility and Coverage Gaps for GLP-1–Based Receptor Agonists in Patients with Obesity Clinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Early Patient-Reported Adverse Events Following Oral Semaglutide Initiation in a Telehealth Setting Clinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm One-Year Weight Loss Among Patients with BMI ≥50 kg/m² Receiving GLP-1 Treatment via Telehealth Clinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Changes in Food Noise and Weight with Semaglutide Injection for Weight Management via Telehealth Obesity pharmacotherapy and drug developmentInterventional and clinical studies Poster Mon Nov 16 2:30pm–3:30pm Cancer Prevalence and Associations in Treatment-Seeking Telehealth Patients with Overweight/Obesity Chronic disease and obesity complications |
Virtual clinic treating type 2 diabetes and obesity with carbohydrate-reduced nutrition therapy, coaching and medication management. | Poster Sat Nov 14 7:30pm–8:30pm Impact of Digitally Delivered Nutrition Therapy on Healthcare Costs in a Medicare Population Chronic disease and obesity complications Poster Sat Nov 14 7:30pm–8:30pm Improved Sleep and Cognitive Function After 6 Months in a Carbohydrate-Reduced Nutrition Program Neuroscience of appetite and eating Poster Mon Nov 16 2:30pm–3:30pm Healthcare Costs in Obesity: Digital Carbohydrate-Reduced Nutrition Vs Incretin-Based Therapy Interventional and clinical studies Poster Mon Nov 16 2:30pm–3:30pm Prevalence of Clinical and Preclinical Obesity in Nationwide Carbohydrate-Reduced Telemedicine Clinic Chronic disease and obesity complications Poster Mon Nov 16 2:30pm–3:30pm Improved Pain Is Associated With Greater Work Productivity in Overweight and Obese Population Chronic disease and obesity complications |
Obesity medicine provider offering in-person and virtual care that combines medication, nutrition and behavioral support. | Talk Sat Nov 14 1:45pm–2:00pm Poster Sun Nov 15 2:30pm–3:30pm Engagement as a Modifiable Driver of GLP-1 Outcomes in Real-World Obesity Care Clinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Obesity Medicine Certification Enhances GLP-1 Receptor Agonist Outcomes Through 18 Months: A Real-World Multi-Site Cohort Study Clinical obesity care and professional practice |
Calibrate New York, NY | |
Virtual metabolic health program that pairs GLP-1 prescriptions with coaching on food, sleep, exercise and emotional health. | Poster Sun Nov 15 2:30pm–3:30pm Sustained 4-Year Weight Loss by BMI: A Retrospective Analysis of a GLP-1 Metabolic Reset Program Interventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Impact of Coaching and Digital Tracking on 12-Month Weight Loss in a GLP-1 Metabolic Reset Program Interventional and clinical studies |
Continuing medical education company running clinician programs, including education on obesity care. | Poster Sun Nov 15 2:30pm–3:30pm Closing the Evidence-To-Practice Gap in Obesity Management for Heart Failure With Preserved Ejection Fraction: Outcomes From a Large-Scale Multimodal Educational Initiative Obesity pharmacotherapy and drug developmentPolicy and public health Poster Mon Nov 16 2:30pm–3:30pm |
Health economics, outcomes research and real-world evidence firm within Thermo Fisher Scientific's PPD clinical research business. | Poster Sun Nov 15 2:30pm–3:30pm Inclusion of Qualitative Interviews in Clinical Trials for Obesity Management Medications: A Review Interventional and clinical studies Poster Mon Nov 16 2:30pm–3:30pm Introducing the PPD CorEvitas Obesity Registry: Patient’s Experience of Obesity Treatments Interventional and clinical studies |
Virtual obesity-medicine practice offering physician-led weight care that combines medication, nutrition and behavioral support. | Session Sun Nov 15 9:30am–10:30am Talk Mon Nov 16 11:30am–1:15pm The Evolution of Obesity Management: Incorporating a Maturing Science into Clinical Practice Case-based discussion of treating obesity as a lifelong chronic disease, with personalized drug choice, combination therapy and continued treatment. Clinical obesity care and professional practiceObesity pharmacotherapy and drug development |
Omada Health San Francisco, CA | |
Virtual care provider for diabetes, hypertension, musculoskeletal conditions and weight management. | Poster Sat Nov 14 7:30pm–8:30pm Poster Sun Nov 15 2:30pm–3:30pm Virtual Lifestyle Program Support for GLP‑1 Therapy: 12‑Month Persistence and Weight Outcomes Clinical obesity care and professional practice |
UK online weight-loss service that pairs prescribed GLP-1 medication with an app and clinical coaching. | Poster Sat Nov 14 7:30pm–8:30pm Precision Medicine for GLP-1 Therapy, Heterogeneous Benefit of Tirzepatide Vs Semaglutide Chronic disease and obesity complicationsObesity pharmacotherapy and drug development Poster Sun Nov 15 2:30pm–3:30pm Maximum Early-Period Weight Loss (Months 1–3) Predicts 12‑Month GLP‑1 Response in a Real-World Cohort Interventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Baseline Predictors of 12-Month Real-World Weight Loss on GLP-1 Therapy: 143,343 Adults Interventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Predictors of 12-Month Weight Loss with Tirzepatide: A Real-World Study of 88,538 Adults Interventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Cost-effectiveness of Tirzepatide plus Digital Support for Obesity: Real-World Microsimulation Model Interventional and clinical studies Talk Mon Nov 16 10:10am–10:15am Maximum Early-Period Weight Loss (Months 1–3) Predicts 12-Month GLP-1 Response in a Real-World Cohort Metabolism and integrative physiologyNeuroscience of appetite and eatingInterventional and clinical studiesPopulation health and epidemiologyPolicy and public health |
Numan London, UK | |
Digital health company offering online weight-loss programmes that pair GLP-1 medication with coaching. | Poster Sat Nov 14 7:30pm–8:30pm Patient-Identified Challenges and Coaching Preferences at Entry Into a GLP-1 Based Digital Care Programme Neuroscience of appetite and eating Talk Sun Nov 15 9:15am–9:30am Poster Sun Nov 15 2:30pm–3:30pm Differential Efficacy of GLP-1 Based Treatment With or Without Wraparound Care Engagement Interventional and clinical studies Poster Mon Nov 16 2:30pm–3:30pm Metabolic Improvements in Patients on a GLP-1 Based Digital Treatment Programme Chronic disease and obesity complications |
WeightWatchers New York, NY | |
Weight-management company pairing its behavioral program with a telehealth clinic that prescribes obesity medications. | Poster Sat Nov 14 7:30pm–8:30pm Three-Month Weight Loss Effectiveness of Oral Semaglutide in a Telehealth Weight Management Program Metabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm Three-Year Weight Loss Outcomes of a Real-World Telehealth Medical Weight Management Program Metabolism and integrative physiology Poster Sun Nov 15 2:30pm–3:30pm Comparative Effectiveness of Commercial Weight Management Programs: A Randomized Controlled Trial Clinical obesity care and professional practice Talk Mon Nov 16 1:45pm–2:00pm Focus on Transitioning from Academia to Industry as Mid-Career Researcher Metabolism and integrative physiologyNeuroscience of appetite and eatingInterventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practicePolicy and public health |
Find buyers from digital health and service companies
Tell us what you sell and we’ll find the people at these digital health and service companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse ObesityWeek 2026 by
Organization type
Topic
- Obesity pharmacotherapy and drug development 251
- Clinical obesity care and professional practice 196
- Interventional and clinical studies 231
- Metabolism and integrative physiology 217
- Nutrition, diet and food 164
- Pediatric and adolescent obesity 117
- Population health and epidemiology 156
- Chronic disease and obesity complications 224
- Neuroscience of appetite and eating 97
- Bariatric surgery and devices 58
- Policy and public health 102
Exhibit hall
Everyone
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction